Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Abstract
The use of stem cell-derived dopamine neurons or deep brain stimulation (DBS) represents two alternative approaches to treat Parkinson's Disease. DBS is a widely used FDA-approved treatment and stem cell-derived dopamine neuron replacement has now evolved to the first in-human clinical trials. In this debate, we discuss which of these approaches will evolve to be the treatment of choice for Parkinsonian patients in the future.
Description
Journal Title
J Parkinsons Dis
Conference Name
Journal ISSN
1877-7171
1877-718X
1877-718X
Volume Title
11
Publisher
SAGE Publications
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as All rights reserved
Sponsorship
Medical Research Council (MC_PC_17230)
